Studies on the prevalence of blindness in Ethiopia: a protocol for the systematic review and meta-analysis,BMJ Open Ophthalmology

当前位置： X-MOL 学术 › BMJ Open Ophthalmol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Studies on the prevalence of blindness in Ethiopia: a protocol for the systematic review and meta-analysis
BMJ Open Ophthalmology Pub Date : 2021-09-01 , DOI: 10.1136/bmjophth-2021-000881
Merkineh Markos ₁ , Biruktawit Kefyalew ₂ , Hana Belay Tesfaye ₃

Affiliation

Introduction Blindness refers to a lack of vision and/or defined as presenting visual acuity worse than 3/60 in the better eye. Its highest proportion has been conforming to the developing countries such as Ethiopia. So, timely information is crucial to design strategies. However, the study on the magnitude of blindness in Ethiopia was outdated, that means it was conducted in 2005–2006. Therefore, this protocol has been proposed to estimate the pooled prevalence of blindness in Ethiopia to provide up-to-date, comprehensive evidence on this theme. Methods and analysis The following databases will be used to search articles: PubMed, Cochrane Library, Google Scholar and retrieving references. Standard data extraction approach will be employed and presented using Preferred Reporting Items for Systematic Review and Meta-Analysis. The Newcastle–Ottawa Scale quality assessment tool will be used to evaluate the quality of studies. Analysis will be held using STATA V.11. Funnel plot and Egger’s regression test will be applied to check for the potential sources of bias. Heterogeneity among the studies will be tested using Higgins method in which I² statistics will be calculated and compared with the standard. Meta-regression and subgroup analysis will be done to identify the potential sources of heterogeneity. Cross-sectional and survey studies conducted in Ethiopia and published in English language will be included. Ethics and dissemination Ethics approval and consent are not required. On completion, the result will be submitted to a reputable peer-reviewed journal. Trial registration number CRD42021268448. Data are available upon reasonable request. All data relevant to the study are included in the article or uploaded as supplemental information. Not applicable.

更新日期：2021-09-21

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文

全部期刊列表>>